Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Aug;26(2):191–194. doi: 10.1111/j.1365-2125.1988.tb03387.x

Predicting the ciprofloxacin-theophylline interaction from single plasma theophylline measurements.

K A Bachmann 1, J I Schwartz 1, L Jauregui 1
PMCID: PMC1386528  PMID: 3207556

Abstract

The effect of ciprofloxacin treatment on theophylline clearance was evaluated with a theophylline multiple dose, multiple sample protocol and with a single dose, single sample protocol. The object was to determine whether a single dose, single sample protocol for estimating theophylline clearance could be used as a screening strategy for evaluating host factor influences on theophylline clearance. Ciprofloxacin (750 mg per os) was administered every 12 h for nine doses in the multidose study and every 12 h for seven doses in the single dose protocol. Subjects were sixteen healthy, non-smoking young adult males. The oral clearance of theophylline at steady state, (CL/F)ss, decreased from a mean (+/- s.d.) value of 0.035 (+/- 0.008) 1 h-1 kg-1 to 0.024 (+/- 0.004) 1 h-1 kg-1 during ciprofloxacin treatment. Single sample estimates of theophylline clearance, CL/F, similarly decreased from 0.040 (+/- 0.014) 1 h-1 kg-1 to 0.018 (+/- 0.008) 1 h-1 kg-1. Mean theophylline clearances were significantly different when comparing control with ciprofloxacin treatment means (P less than 0.01), but were not different when comparing single sample vs multiple sample clearances for a given treatment (i.e. control or ciprofloxacin). It is concluded that a single dose, single sample strategy may be used in screening for host-factor influences on theophylline clearance.

Full text

PDF
192

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachmann K. Estimating the clearance of amylobarbitone from a single plasma measurement. Br J Clin Pharmacol. 1987 Jan;23(1):94–98. doi: 10.1111/j.1365-2125.1987.tb03016.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bachmann K., Schwartz J., Forney R., Jr, Jauregui L. Phenytoin as a probe of drug metabolism. Predicting clearance with a salivary sample. Pharmacology. 1985;30(3):145–152. doi: 10.1159/000138063. [DOI] [PubMed] [Google Scholar]
  3. Bachmann K., Schwartz J., Forney R., Jr, Jauregui L. Theophylline kinetics: dose dependency and single sample prediction of clearance. Pharmacology. 1985;30(3):136–144. doi: 10.1159/000138062. [DOI] [PubMed] [Google Scholar]
  4. Bachmann K., Schwartz J., Sullivan T., Jauregui L. Single sample estimate of ethosuximide clearance. Int J Clin Pharmacol Ther Toxicol. 1986 Oct;24(10):546–550. [PubMed] [Google Scholar]
  5. Dandliker W. B., Kelly R. J., Dandliker J., Farquahar J., Levin J. Fluorescence polarization immunoassay. Theory and experimental method. Immunochemistry. 1973 Apr;10(4):219–227. doi: 10.1016/0019-2791(73)90198-5. [DOI] [PubMed] [Google Scholar]
  6. Døssing M., Poulsen H. E., Andreasen P. B., Tygstrup N. A simple method for determination of antipyrine clearance. Clin Pharmacol Ther. 1982 Sep;32(3):392–396. doi: 10.1038/clpt.1982.177. [DOI] [PubMed] [Google Scholar]
  7. Jolley M. E. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. J Anal Toxicol. 1981 Sep-Oct;5(5):236–240. doi: 10.1093/jat/5.5.236. [DOI] [PubMed] [Google Scholar]
  8. Mitchard M., Harris A., Mullinger B. M. Ranitidine drug interactions--a literature review. Pharmacol Ther. 1987;32(3):293–325. doi: 10.1016/0163-7258(87)90078-7. [DOI] [PubMed] [Google Scholar]
  9. Nix D. E., DeVito J. M., Whitbread M. A., Schentag J. J. Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. J Antimicrob Chemother. 1987 Feb;19(2):263–269. doi: 10.1093/jac/19.2.263. [DOI] [PubMed] [Google Scholar]
  10. Raoof S., Wollschlager C., Khan F. A. Ciprofloxacin increases serum levels of theophylline. Am J Med. 1987 Apr 27;82(4A):115–118. [PubMed] [Google Scholar]
  11. Schwartz J., Jauregui L., Lettieri J., Bachmann K. Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum. Antimicrob Agents Chemother. 1988 Jan;32(1):75–77. doi: 10.1128/aac.32.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wijnands W. J., Vree T. B., van Herwaarden C. L. The influence of quinolone derivatives on theophylline clearance. Br J Clin Pharmacol. 1986 Dec;22(6):677–683. doi: 10.1111/j.1365-2125.1986.tb02957.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES